BioSpace News Archive

Business

Tigermed Reports Full Year 2023 Results

Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.

March 28, 2024
·
9 min read
Drug Development

Affimed Reports 2023 Financial Results and Operational Progress

Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the year ended December 31, 2023.

March 28, 2024
·
15 min read
Business

DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results

DarioHealth Corp., a leader in the global digital health market, reported financial results for the fourth quarter 2023 and the full year 2023 and provided a corporate and commercial update.

March 28, 2024
·
27 min read
Business

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

Monopar Therapeutics Inc. announced fourth quarter and full-year 2023 financial results and summarized recent developments.

March 28, 2024
·
6 min read
BioMidwest

Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics

Kraig Biocraft Laboratories, Inc., comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute.

March 28, 2024
·
3 min read
Bio NC

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for etripamil, the Company’s lead investigational product for the management of paroxysmal supraventricular tachycardia (PSVT).

March 28, 2024
·
7 min read
Biotech Bay

Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results

Apollomics Inc. announced financial results for the full year ended December 31, 2023, and highlighted progress of its pipeline.

March 28, 2024
·
12 min read
Business

Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced financial results for the full year ended December 31, 2023 and recent business highlights.

March 28, 2024
·
23 min read
Business

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

March 28, 2024
·
10 min read
Genetown

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Xilio Therapeutics, Inc. announced that it has entered into a securities purchase agreement with certain existing accredited investors, including Bain Capital Life Sciences and Rock Springs Capital.

March 28, 2024
·
15 min read